Skip to main content
Top
Published in: Skeletal Radiology 6/2016

01-06-2016 | Test Yourself: Answer

Hip pain

Authors: Nathan R. Webb, M. K. Jesse

Published in: Skeletal Radiology | Issue 6/2016

Login to get access

Excerpt

Diagnosis: Bisphosphonate-related atypical subtrochanteric femoral fracture in patient with Paget disease. …
Literature
1.
go back to reference Paget J. On a form of chronic inflammation of bones (osteitis deformans). Med Chir Trans (Lond). 1877;60:37–64.CrossRef Paget J. On a form of chronic inflammation of bones (osteitis deformans). Med Chir Trans (Lond). 1877;60:37–64.CrossRef
2.
go back to reference Theodorou D, Theodorou S, Kakitsubata Y. Imaging of Paget disease of bone and its musculoskeletal complications: review. AJR. 2011;196:S64–5.CrossRefPubMed Theodorou D, Theodorou S, Kakitsubata Y. Imaging of Paget disease of bone and its musculoskeletal complications: review. AJR. 2011;196:S64–5.CrossRefPubMed
3.
go back to reference Mirra JM, Brien EW, Tehranzadeh J. Paget’s disease of bone: review with emphasis on radiologic features—part I. Skelet Radiol. 1995;24:163–71. Mirra JM, Brien EW, Tehranzadeh J. Paget’s disease of bone: review with emphasis on radiologic features—part I. Skelet Radiol. 1995;24:163–71.
4.
5.
go back to reference Reid IR. Pharmacotherapy of Paget’s disease of bone. Expert Opin Pharmacother. 2012;13(5):637–46.CrossRefPubMed Reid IR. Pharmacotherapy of Paget’s disease of bone. Expert Opin Pharmacother. 2012;13(5):637–46.CrossRefPubMed
7.
go back to reference Porrino Jr JA, Kohl CA, Taljanovic M, Rogers LF. Diagnosis of proximal femoral insufficiency fractures in patients receiving bisphosphonate therapy. AJR. 2010;194:1061–4.CrossRefPubMed Porrino Jr JA, Kohl CA, Taljanovic M, Rogers LF. Diagnosis of proximal femoral insufficiency fractures in patients receiving bisphosphonate therapy. AJR. 2010;194:1061–4.CrossRefPubMed
8.
go back to reference Rogers LF, Taljanovic M. FDA statement on relationship between bisphosphonate use and atypical subtrochanteric and femoral shaft fractures: a considered opinion. AJR. 2010;195:563–6.CrossRefPubMed Rogers LF, Taljanovic M. FDA statement on relationship between bisphosphonate use and atypical subtrochanteric and femoral shaft fractures: a considered opinion. AJR. 2010;195:563–6.CrossRefPubMed
9.
go back to reference Kilcoyne A, Heffernan E. Atypical proximal femoral fractures in patients with Paget disease receiving bisphosphonate therapy. AJR. 2011;197(1):W196–7.CrossRefPubMed Kilcoyne A, Heffernan E. Atypical proximal femoral fractures in patients with Paget disease receiving bisphosphonate therapy. AJR. 2011;197(1):W196–7.CrossRefPubMed
10.
go back to reference Teo BJ, Koh JS, Goh SK, Png MA, Chua DT, Howe TS. Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy. Bone Joint J. 2014;96-B(5):658–64.CrossRefPubMed Teo BJ, Koh JS, Goh SK, Png MA, Chua DT, Howe TS. Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy. Bone Joint J. 2014;96-B(5):658–64.CrossRefPubMed
Metadata
Title
Hip pain
Authors
Nathan R. Webb
M. K. Jesse
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 6/2016
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-016-2337-3

Other articles of this Issue 6/2016

Skeletal Radiology 6/2016 Go to the issue

Browser's Notes

Browser’s Notes